Blood test may spare some women from radiation after endometrial cancer surgery

NCT ID NCT07339384

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a blood test that detects tumor DNA can help decide if women with early-stage endometrial cancer need radiation after surgery. About 1,010 women will be followed for two years. Those with a negative blood test may safely skip radiation, while others receive standard care. The goal is to see if the blood test-guided approach works just as well as usual treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Allegheny Health

    Pittsburgh, Pennsylvania, 15224, United States

  • Atrium Health Levine Cancer

    Charlotte, North Carolina, 28204, United States

  • Cleveland Clinic

    Cleveland, Ohio, 44106, United States

  • Duke University

    Durham, North Carolina, 27708, United States

  • New York University

    New York, New York, 10016, United States

  • Ohio State University Wexner Medical Center

    Columbus, Ohio, 43210, United States

  • University of Alabama at Birmingham Hospital

    Birmingham, Alabama, 35294, United States

  • University of California, Los Angeles

    Los Angeles, California, 90095, United States

  • University of California, San Diego

    La Jolla, California, 92093, United States

  • University of Chicago

    Chicago, Illinois, 60637, United States

  • University of Miami

    Miami, Florida, 33146, United States

  • University of Minnesota

    Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.